全文获取类型
收费全文 | 2144篇 |
免费 | 101篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 90篇 |
妇产科学 | 58篇 |
基础医学 | 226篇 |
口腔科学 | 26篇 |
临床医学 | 167篇 |
内科学 | 446篇 |
皮肤病学 | 41篇 |
神经病学 | 90篇 |
特种医学 | 244篇 |
外科学 | 381篇 |
综合类 | 84篇 |
预防医学 | 128篇 |
眼科学 | 26篇 |
药学 | 111篇 |
中国医学 | 6篇 |
肿瘤学 | 128篇 |
出版年
2023年 | 23篇 |
2022年 | 12篇 |
2021年 | 39篇 |
2020年 | 36篇 |
2019年 | 58篇 |
2018年 | 51篇 |
2017年 | 39篇 |
2016年 | 35篇 |
2015年 | 44篇 |
2014年 | 87篇 |
2013年 | 95篇 |
2012年 | 125篇 |
2011年 | 135篇 |
2010年 | 60篇 |
2009年 | 67篇 |
2008年 | 98篇 |
2007年 | 115篇 |
2006年 | 111篇 |
2005年 | 89篇 |
2004年 | 76篇 |
2003年 | 64篇 |
2002年 | 46篇 |
2001年 | 26篇 |
2000年 | 42篇 |
1999年 | 30篇 |
1998年 | 41篇 |
1997年 | 48篇 |
1996年 | 51篇 |
1995年 | 30篇 |
1994年 | 29篇 |
1993年 | 30篇 |
1992年 | 31篇 |
1991年 | 17篇 |
1990年 | 22篇 |
1989年 | 32篇 |
1988年 | 27篇 |
1987年 | 29篇 |
1986年 | 32篇 |
1985年 | 18篇 |
1984年 | 15篇 |
1983年 | 15篇 |
1982年 | 23篇 |
1980年 | 15篇 |
1978年 | 18篇 |
1977年 | 13篇 |
1976年 | 18篇 |
1975年 | 17篇 |
1973年 | 13篇 |
1971年 | 11篇 |
1968年 | 11篇 |
排序方式: 共有2263条查询结果,搜索用时 15 毫秒
1.
Heather G. Lyu MD Adil H. Haider MD MPH Adam B. Landman MD MS MIS MHS Chandrajit P. Raut MD MSc 《Cancer》2019,125(17):2926-2934
The rarity and heterogeneity of sarcomas make performing appropriately powered studies challenging and magnify the significance of large databases in sarcoma research. Established large tumor registries and population-based databases have become increasingly relevant for answering clinical questions regarding sarcoma incidence, treatment patterns, and outcomes. However, the validity of large databases has been questioned and scrutinized because of the inaccuracy and wide variability of coding practices and the absence of clinically relevant variables. In addition, the utilization of large databases for the study of rare cancers such as sarcoma may be particularly challenging because of the known limitations of administrative data and poor overall data quality. Currently, there are several large national cancer databases, including the Surveillance, Epidemiology, and End Results database, the National Cancer Data Base of the American College of Surgeons and the American Cancer Society, and the National Program of Cancer Registries of the Centers for Disease Control and Prevention. These databases are often used for sarcoma research, but they are limited by their dependence on administrative or billing data, the lack of agreement between chart abstractors on diagnosis codes, and the use of preexisting documented hospital diagnosis codes for tumor registries, which lead to a significant underestimation of sarcomas in large data sets. Current and future initiatives to improve databases and big data applications for sarcoma research include increasing the utilization of sarcoma-specific registries and encouraging national initiatives to expand on real-world, evidence-based data sets. 相似文献
2.
Theresa Y. Kim Muhiuddin Haider Gregory R. Hancock Michel H. Boudreaux 《Journal of health communication》2019,24(3):244-261
Health communication has contributed to an increase in family planning use through education and mass media as a means to increase health literacy. In this research, we investigate health literacy as an auxiliary component of health communication. We test the validity of the Health Literacy Skills Framework by examining the correlation of health literacy indicators to family planning use among Senegalese women in the 2014 Demographic Health Survey. We found that increased family planning use was most strongly associated with hearing family planning messages through television and radio. Other health literacy indicators, including access to printed family planning messaging, textual literacy, and knowledge of ovulatory cycles did not strengthen family planning use, even when performing a subgroup analysis of women who could read. The implications are that the Health Literacy Skills framework can measure health literacy’s ability (assessed through proxy indicators of health literacy) to predict modern family planning use among Senegalese women and that audio and visual health literacy measures are most strongly associated with increased family planning use. 相似文献
3.
4.
Shahid Ahmed MD PhD FRCPC Sukanya Pati MD Duc Le MD MSc FRCPC Kamal Haider MD Nayyar Iqbal MD FRCP 《Journal of surgical oncology》2020,122(2):144-154
Over the past two decades, gene expression profiling of breast cancer has emerged as an important tool in early-stage breast cancer management. The approach provides important information on underlying biological mechanisms, breast cancer classification, future risk potential of developing recurrent metastatic disease, and provides beneficial clues for adjuvant chemotherapy in hormone receptor (HR) positive breast cancer. Of the commercially available genomic tests for breast cancer, the prognostic and predictive value of 21-gene recurrence score tests have been validated using both retrospective data and prospective clinical trials. In this paper, we reviewed the current evidence on 21-gene expression profiles for HR-positive HER2-negative early-stage breast cancer management. We show that current evidence supports endocrine therapy alone as an appropriate adjuvant systemic therapy for approximately 70% of women with HR-positive, HER2-negative, node-negative breast cancer. Evolving evidence also suggests that 21-gene recurrence scores have predictive values for node-positive breast cancer and that chemotherapy can be avoided in more than half of women with nodes 1 to 3 positive HR-positive breast cancer. Furthermore, retrospective data also supports the predictive role of 21-gene recurrence scores for adjuvant radiation therapy. A prospective trial in this area is ongoing. 相似文献
5.
6.
7.
8.
Matteo Morotti Christos E. Zois Rokaya El-Ansari Madeleine L. Craze Emad A. Rakha Shih-Jung Fan Alessandro Valli Syed Haider Deborah C. I. Goberdhan Andrew R. Green Adrian L. Harris 《British journal of cancer》2021,124(2):494
Background Glutamine (Gln) is an abundant nutrient used by cancer cells. Breast cancers cells and particularly triple-receptor negative breast cancer (TNBC) are reported to be dependent on Gln to produce the energy required for survival and proliferation. Despite intense research on the role of the intracellular Gln pathway, few reports have focussed on Gln transporters in breast cancer and TNBC.Methods The role and localisation of the Gln transporter SLC38A2/SNAT2 in response to Gln deprivation or pharmacological stresses was examined in a panel of breast cancer cell lines. Subsequently, the effect of SLC38A2 knockdown in Gln-sensitive cell lines was analysed. The prognostic value of SLC38A2 in a cohort of breast cancer was determined by immunohistochemistry.Results SLC38A2 was identified as a strongly expressed amino acid transporter in six breast cancer cell lines. We confirmed an autophagic route of degradation for SLC38A2. SLC38A2 knockdown decreased Gln consumption, inhibited cell growth, induced autophagy and led to ROS production in a subgroup of Gln-sensitive cell lines. High expression of SLC38A2 protein was associated with poor breast cancer specific survival in a large cohort of patients (p = 0.004), particularly in TNBC (p = 0.02).Conclusions These results position SLC38A2 as a selective target for inhibiting growth of Gln-dependent breast cancer cell lines.Subject terms: Breast cancer, Cancer metabolism 相似文献
9.
10.
Noreen Roshan Ali Syed Lal Badshah Muhammad Faheem Sumra Wajid Abbasi Riaz Ullah Ahmed Bari Syed Babar Jamal Hafiz Majid Mahmood Adnan Haider Sajjad Haider 《Saudi Pharmaceutical Journal》2020,28(12):1580-1591
Zika virus (ZIKV) is one of the mosquito borne flavivirus with several outbreaks in past few years in tropical and subtropical regions. The non-structural proteins of flaviviruses are suitable active targets for inhibitory drugs due to their role in pathogenicity. In ZIKV, the non-structural protein 5 (NS5) RNA-Dependent RNA polymerase replicates its genome. Here we have performed virtual screening to identify suitable ligands that can potentially halt the ZIKV NS5 RNA dependent RNA polymerase (RdRp). During this process, we searched and screened a library of ligands against ZIKV NS5 RdRp. The selected ligands with significant binding energy and ligand-receptor interactions were further processed. Among the selected docked conformations, top five was further optimized at atomic level using molecular dynamic simulations followed by binding free energy calculations. The interactions of ligands with the target structure of ZIKV RdRp revealed that they form strong bonds within the active sites of the receptor molecule. The efficacy of these drugs against ZIKV can be further analyzed through in-vitro and in-vivo studies. 相似文献